AFFF Firefighter Foam PFAS Lawsuit MDL 2873 — 2026 Guide

Let’s clear up the biggest misconception in the AFFF lawsuit space immediately.

3M settled for $10.3 billion. That money goes to municipal water utilities to fund PFAS cleanup in drinking water systems. Not one dollar of that settlement goes to a firefighter who developed kidney cancer after decades of AFFF exposure.

The personal injury track — firefighters, military personnel, airport workers — remains open and unresolved. MDL 2873 before Judge Richard M. Gergel in South Carolina currently has more than 15,000 pending cases. No bellwether trial has been held yet. No global personal injury settlement exists.

If you were exposed to AFFF occupationally and have since been diagnosed with kidney cancer, testicular cancer, bladder cancer, or another qualifying condition, this guide covers what the litigation actually looks like and what your path to compensation involves.

This is not legal advice. Consult a qualified attorney for your specific situation.

What AFFF Is and Why It Causes Cancer

AFFF (Aqueous Film-Forming Foam) was the standard firefighting agent for petroleum-based fires for decades — used at military air bases, commercial airports, industrial facilities, and in training programs. It works by rapidly smothering flames with a film that cuts off oxygen.

The cancer risk comes from its active chemistry: PFAS — per- and polyfluoroalkyl substances, a class of thousands of synthetic compounds built around carbon-fluorine bonds. That bond is essentially indestructible in nature, which is why PFAS is called “forever chemicals.”

The three PFAS subtypes most relevant to AFFF litigation:

Compound	Primary Health Concerns
PFOA (perfluorooctanoic acid)	Kidney cancer, testicular cancer, thyroid disease
PFOS (perfluorooctane sulfonic acid)	Thyroid dysfunction, immune suppression
PFHxS (perfluorohexane sulfonic acid)	Thyroid, liver function

In April 2024, the EPA finalized the first-ever National Primary Drinking Water Regulation for PFAS, setting the Maximum Contaminant Level for PFOA and PFOS at 4 parts per trillion — the lowest concentration laboratories can reliably measure. The EPA set the Maximum Contaminant Level Goal (MCLG) at zero, acknowledging no safe threshold exists.

Firefighters were exposed through skin contact during use, inhalation of aerosol mist during training burns, and ingestion of PFAS-contaminated groundwater at training facilities. Studies of AFFF training sites have found PFAS contamination at levels orders of magnitude above the EPA’s new 4 ppt standard.

Asbestos exposure lawsuit claims and compensation →

MDL 2873: Structure and Current Status

The Litigation at a Glance

Element	Detail
MDL Number	MDL 2873
Case Name	In re Aqueous Film-Forming Foams Products Liability Litigation
Court	U.S. District Court, District of South Carolina
Judge	Richard M. Gergel
Pending Cases	~15,213 (as of January 2026)
Authorizing Statute	28 U.S.C. § 1407

MDL is not a class action. Each plaintiff retains an individual case. The MDL mechanism, authorized by 28 U.S.C. § 1407 and administered by the Judicial Panel on Multidistrict Litigation (JPML), consolidates pretrial proceedings — discovery, Daubert hearings, case management orders — in a single court to prevent inconsistent rulings and duplicative work.

Two Separate Tracks — Critical Distinction

Water Utility Track: Claims by municipalities and water authorities seeking PFAS cleanup costs.

• 3M’s $10.3 billion settlement (finalized March 2024): covers public water systems only
• DuPont/Chemours/Corteva’s $1.185 billion settlement (announced June 2023): also covers water systems only
• Both settled. Neither involves personal injury.

Personal Injury Track: Claims by firefighters, military personnel, and airport workers with cancer diagnoses.

• No settlement reached
• No bellwether trial completed
• First bellwether pulled from October 2025 calendar; new date not set as of May 2026

This distinction matters enormously. When you read a headline saying “AFFF defendants settle for billions,” it tells you nothing about what personal injury claimants will receive.

Why the Bellwether Was Delayed

Over 1,300 new cases were filed in a single month in late 2025 — a filing surge that overwhelmed the court’s documentation verification process. The court determined that the case inventory needed more rigorous screening before a representative bellwether sample could be identified.

The delay means the litigation remains in what practitioners call the “pre-bellwether void” — a period where settlement negotiations occur but without a jury verdict as a reference point. Cases filed now still get into the queue ahead of any global resolution.

Mesothelioma lawsuit compensation overview →

Six Qualifying Conditions

Condition	Scientific Basis
Kidney cancer	Strongest PFAS-cancer link in epidemiology; bellwether priority
Testicular cancer	Elevated incidence in young firefighters; strong mechanistic pathway
Bladder cancer	Long latency; exposure-diagnosis gap of 10–20 years common
Liver cancer	PFOA hepatotoxicity documented in animal and human studies
Thyroid cancer / thyroid disease	PFOS disrupts thyroid hormone synthesis
Ulcerative colitis	Only non-cancer qualifying condition; linked in occupational cohort studies

Research continues on non-Hodgkin lymphoma, breast cancer, and prostate cancer linkages — but the six listed above represent the core, most defensible categories in current litigation.

Eligibility: What You Need to Prove

To bring a successful AFFF personal injury claim, you must establish three elements.

1. Occupational AFFF Exposure

Who qualifies:

• Military firefighters at air bases (any branch)
• Civilian airport fire and rescue personnel
• Industrial firefighters at refineries, petrochemical plants
• Fire training instructors at facilities that used live-fire AFFF exercises
• Navy shipboard firefighting personnel

Exposure documentation you should gather now:

• Employment records from your fire department, military branch, or airport authority
• Training logs or facility records showing AFFF use
• Co-worker declarations confirming AFFF was used at your station
• FOIA requests to your base or facility for AFFF procurement records

2. Qualifying Cancer Diagnosis

Medical records are non-negotiable: pathology report confirming diagnosis, imaging records, treating oncologist notes. AFFF exposure alone, without a confirmed diagnosis, is not a current lawsuit basis.

3. Causal Nexus

Your attorney will typically need an expert oncologist or toxicologist to author a “causation opinion” connecting your exposure history to your diagnosis. This is where Daubert hearings become relevant — before the expert can testify at bellwether trial, the court will evaluate whether the scientific methodology underlying the causation opinion is reliable.

Settlement Structure: What to Expect

With no bellwether verdict yet, settlement ranges are speculative. The industry tracks from Roundup and talc MDLs suggest a tiered matrix approach:

Tier	Criteria	Estimated Range (Speculative)
Tier 1	Long-term occupational exposure + kidney/testicular cancer + documented treatment	$200,000–$600,000
Tier 2	Moderate exposure + qualifying condition + medical records	$150,000–$200,000
Tier 3	Shorter exposure, less severe condition, or weaker documentation	Under $75,000

First bellwether plaintiff win → global settlement negotiations accelerate, thousands of inventory cases compress quickly into a resolution program.

First bellwether plaintiff loss → cases may bifurcate by cancer type, settlement timeline extends, defendants hold tighter on per-case values.

Statute of Limitations: Don’t Assume You’re Too Late

The discovery rule saves many firefighter claims that would otherwise appear time-barred:

State	SOL Period	Notes
California	2 years	From diagnosis or knowledge of PFAS link
New York	3 years	From discovery of injury
Texas	2 years	From diagnosis
Florida	4 years	From discovery
South Carolina	3 years	From discovery

A firefighter who last used AFFF in 2005 but was diagnosed with kidney cancer in 2023 likely still has an active claim window in most states. Do not self-screen out before consulting an attorney.

Medicare Lien: The Hidden Settlement Deduction

If Medicare or Medicaid paid for your cancer treatment, those amounts must be reimbursed from your settlement under the Medicare Secondary Payer Act (MSP, 42 U.S.C. § 1395y(b)). The process:

1. Your attorney requests a conditional payment letter from CMS
2. CMS identifies all AFFF-related payments made
3. After settlement finalization, CMS issues a demand
4. The lien amount is deducted from your gross settlement before disbursement

Liens are negotiable, particularly when the settlement is discounted due to liability disputes. Lien resolution specialists (often engaged by plaintiff firms at no extra cost) can meaningfully reduce the repayment obligation.

Worked Scenarios

Scenario A: Navy Air Base Firefighter (Virginia)

Thomas R., retired 2014 after 22 years at a Navy air base. Used AFFF in quarterly live-fire training and emergency response for the full duration of service. Diagnosed with kidney cancer in 2024.

• Exposure: 22 years, quarterly live-fire, clear AFFF use in military training records
• Diagnosis: Kidney cancer — Tier 1 qualifying condition
• SOL: Virginia 2 years from diagnosis (2024) → must file by 2026
• Medicare lien: Likely applicable; attorney will initiate CMS inquiry
• Assessment: Strong Tier 1 claim if documentation is complete

Scenario B: Airport ARFF Firefighter (Texas)

Sandra L., 19 years with a major Texas hub airport as Aircraft Rescue and Firefighting (ARFF) personnel. Regular AFFF use in training and on-tarmac responses. Diagnosed with thyroid cancer in 2025.

• Exposure: 19 years, ARFF role, airport employment records available
• Diagnosis: Thyroid cancer — qualifying condition
• SOL: Texas 2 years from 2025 diagnosis → file by 2027
• Assessment: Tier 2 likely; thyroid cancer has somewhat weaker epidemiological link than kidney/testicular, but still within established qualifying range

AFFF vs. Roundup vs. Talc: Settlement Structure Comparison

Factor	AFFF MDL 2873	Roundup MDL 2741	J&J Talc MDL 2738
Lead court	D. South Carolina	N.D. California	D. New Jersey
Bellwether status	Not yet held	3 plaintiff wins	Ongoing
Corporate defendant resources	3M, DuPont (strong balance sheets)	Bayer AG	J&J (bankruptcy strategy)
Settlement structure	Anticipated tiered matrix	Individual claim evaluation	Uncertain (bankruptcy)
Water contamination track	Yes (settled $11.5B+)	No	No
Personal injury settlement	None	Partial ($10.9B+)	None

How to Find an Attorney

1. State bar referral services — every state bar has a referral service for product liability attorneys
2. American Association for Justice (AAJ) — the national trial lawyers organization maintains a member directory at justice.org
3. AFFF law firm directories — use as a starting point, not a final decision; compare multiple firms
4. Verify experience: ask specifically about MDL product liability experience and AFFF case count

Initial consultations are free. Attorneys work on contingency — 33–40% of recovery, nothing if you lose.

Roundup non-Hodgkin lymphoma lawsuit guide → Workers compensation vs personal injury claims → Camp Lejeune water contamination lawsuit →

---

The Science Behind PFAS Cancer Claims: What the Research Actually Shows

The litigation does not rest solely on plaintiffs’ expert opinions. Several independent research streams support the biological plausibility of PFAS-induced cancers in firefighters.

National Academies of Sciences, Engineering, and Medicine (NASEM) 2022 Report

The NASEM released a comprehensive review in 2022 concluding there is sufficient evidence of an association between PFAS exposure and kidney cancer, testicular cancer, and thyroid disease, and limited/suggestive evidence for several other cancers. This independent review — not conducted by litigation experts — provided a significant scientific foundation for plaintiff causation arguments.

Occupational Firefighter Cohort Studies

Studies of firefighters specifically (rather than general population PFAS exposure) have found elevated cancer incidence compared to baseline populations. The International Agency for Research on Cancer (IARC) classified firefighting as a Group 1 occupational carcinogen in 2022 — a determination that encompasses PFAS exposure as one contributing mechanism.

PFAS Bioaccumulation in Firefighter Blood

Studies measuring PFAS levels in active firefighter blood have found significantly elevated PFOA and PFOS concentrations compared to the general population. The half-life of PFOS in human blood is approximately 5 years, meaning cumulative exposure from years of AFFF use creates measurable, persistent body burden even years after retirement.

This bioaccumulation data matters in litigation: an expert toxicologist can present a firefighter’s exposure history and connect it to documented cancer mechanism pathways, satisfying the Daubert requirements for scientific methodology.

What Happens During the Claims Process

From First Consultation to Settlement: The Timeline

Understanding what actually happens after you call an attorney reduces uncertainty for claimants considering action.

Phase 1: Intake and Case Assessment (Weeks 1–4) Your attorney reviews employment records, medical records, and exposure history to assess whether your case meets the threshold requirements for MDL participation. You provide: employment documentation, cancer diagnosis records, and a written statement of your AFFF exposure history.

Phase 2: Complaint Filing and MDL Transfer (Weeks 4–12) Your attorney files a complaint in federal court. JPML automatically transfers the complaint to MDL 2873 in South Carolina under 28 U.S.C. § 1407. Your case is assigned a docket number within the MDL.

Phase 3: Plaintiff Fact Sheet Completion (Weeks 8–16) Every MDL 2873 plaintiff must complete a standardized Plaintiff Fact Sheet detailing exposure history, medical diagnosis, employment history, and damages. This is a critical document — inaccuracies can jeopardize your case. Your attorney assists with completion.

Phase 4: Case Management and Discovery Your case enters the MDL’s discovery pipeline. MDL leadership counsel (Plaintiffs’ Steering Committee) conducts global discovery — depositions of corporate witnesses, document production from 3M, DuPont, etc. — on behalf of all plaintiffs. You do not individually depose corporate defendants; the PSC does it collectively.

Phase 5: Bellwether Selection and Trial (or Settlement) Representative cases are tried as bellwethers. Their outcomes drive global settlement negotiations. The vast majority of MDL cases resolve via settlement rather than individual trial.

What “Settlement” Actually Means in an MDL

A global MDL settlement is not automatic. The typical path:

1. Defendants establish a settlement fund of aggregate dollars
2. A Special Master or Claims Administrator applies a tiered matrix to evaluate each plaintiff’s case
3. Your specific settlement offer is calculated based on: cancer type, exposure duration and intensity, age at diagnosis, employment history documentation quality, and damages (medical costs, lost wages, pain and suffering)
4. Your attorney presents the offer to you; you decide whether to accept
5. Medicare/Medicaid liens are resolved from the gross settlement before your net distribution

You retain the right to reject a settlement offer. However, if you reject and proceed to individual trial, you bear the litigation costs and your attorney’s fee typically increases to 40%.

PFAS Regulation Timeline: Why 2024 Rules Matter for Your Case

The EPA’s April 2024 PFAS drinking water rule (effective June 2024) has litigation significance beyond its regulatory purpose.

Setting an MCL of 4 ppt for PFOA and PFOS — the lowest measurable level — is the agency’s implicit acknowledgment that there is no safe exposure threshold. Expert witnesses for plaintiffs routinely cite regulatory history as supporting evidence for the biologically plausible link between PFAS and cancer.

Additionally, the Toxic Substances Control Act (TSCA) Section 8(a) reporting requirements for PFAS compounds have produced a paper trail of internal corporate communications about PFAS health risks that plaintiff discovery teams have targeted in MDL document production requests.

State-Specific Considerations for High-Population States

California: AFFF Exposure at ARFF Facilities

California has numerous military and civilian airport firefighting facilities — Los Angeles International (LAX), San Diego International, Travis Air Force Base, Edwards Air Force Base among them. California’s 2-year statute of limitations runs from diagnosis. California Code of Civil Procedure § 335.1 governs personal injury claims. California also has the Discovery Act (CCP § 340.1 for delayed discovery claims) which can provide extended windows in latent injury cases.

Texas: Petroleum Industry and Military Bases

Texas has a dense cluster of petrochemical refineries where AFFF was used routinely, plus major military installations (Fort Cavazos, Randolph Air Force Base, Joint Base San Antonio). Texas Civ. Prac. & Rem. Code § 16.003 sets a 2-year personal injury limitations period. Texas also has the discovery rule in its common law, triggered when the plaintiff discovers or in the exercise of reasonable diligence should discover the injury.

Florida: Military and Space Coast Facilities

Kennedy Space Center, Patrick Space Force Base, and numerous naval air stations operated in AFFF-intensive environments. Florida § 95.11(3)(a) provides a 4-year limitation for product liability claims — the most generous of the major states — running from date of discovery.

New York: Fire Training Academies

New York has several prominent fire training academies and industrial facilities. New York CPLR § 214-c governs latent injury claims, providing a 3-year period from discovery (with potential 1-year discovery extension from the date toxic substance exposure was linked to injury via scientific knowledge).

The DuPont/Chemours/Corteva Settlement and Its Limits

In June 2023, DuPont de Nemours, Chemours, and Corteva announced a preliminary agreement of $1.185 billion to address PFAS-related drinking water claims from public water systems. Like the 3M settlement, this covers only the environmental contamination track — not personal injury claims by firefighters or other exposed individuals.

Understanding why these water utility settlements are separate from personal injury matters requires a grasp of the corporate defendant structure:

DuPont’s PFAS History: DuPont manufactured PFOA (C8) for decades at its Washington Works plant in Parkersburg, West Virginia. Internal documents later made public in the MDL discovery process showed DuPont scientists knew about PFOA toxicity for decades before regulators required action. The C8 Health Project, a science panel funded as part of a settlement with community members near the Parkersburg plant, established probable links between PFOA exposure and six diseases: kidney cancer, testicular cancer, ulcerative colitis, thyroid disease, pre-eclampsia, and hypercholesterolemia. These “C8” diseases are directly relevant to AFFF personal injury theory.

Chemours’ Spinoff: DuPont spun off Chemours in 2015, transferring much of its legacy PFAS liability. Both Chemours and DuPont remain defendants in PFAS litigation.

Corteva’s Formation: DuPont and Dow Chemical merged in 2017 then split into three companies: DuPont (specialty products), Dow (materials science), and Corteva (agriculture). Corteva inherited agricultural PFAS-related liabilities.

The $1.185 billion settlement for water utilities — like 3M’s settlement — does not bind or benefit firefighters filing personal injury claims. It demonstrates that PFAS defendants have the resources and willingness to settle at scale, which is a relevant signal for future personal injury negotiations.

Corporate Defendants’ Balance Sheets: Why This Matters

The ability to pay a large settlement is not automatic. AFFF personal injury litigation involves defendants with substantial resources:

3M Company: Revenues of approximately $23 billion annually. 3M settled the water utility claims partly to reduce uncertainty in its financial planning. However, its 2025 spinoff of certain business units changes the corporate structure. Litigants should verify current 3M corporate structure with their attorneys.

DuPont de Nemours: Post-2017 restructuring reduced its balance sheet exposure. The $1.185 billion water utility settlement represented a manageable hit.

Chemours Company: Spun off from DuPont specifically to absorb PFAS liabilities. Chemours has faced financial strain from ongoing environmental remediation obligations. This creates a settlement negotiation dynamic where Chemours has less capacity to offer than DuPont or 3M.

The personal injury settlement fund, when ultimately negotiated, will likely involve contributions from multiple defendants at different percentages based on market share and period of sale. Understanding defendant-specific financial capacity helps set realistic expectations about timing and per-case recovery.

Long-Term Health Monitoring for Firefighters

Even firefighters who have not yet received a cancer diagnosis but who have documented AFFF exposure may have options beyond waiting for diagnosis:

PFAS Blood Testing: Commercial labs now offer PFAS blood panel testing. Elevated PFOA or PFOS levels in blood establish an objective biomarker of exposure. This documentation, obtained now, can strengthen a future claim if cancer develops.

Medical Surveillance Programs: Some states (including New Hampshire, Michigan, and Vermont) have established PFAS health registries for firefighters that include periodic blood testing and health monitoring. Federal firefighter health surveillance programs through the National Institute for Occupational Safety and Health (NIOSH) also exist.

AFFF Exposure Documentation Now: If you worked at a facility that used AFFF, filing a FOIA request now — while your employer still has those records — is prudent. FOIA processing times average 3–18 months; records you need in 2028 should be requested in 2026.

Current Legislation: The PFAS Accountability Act of 2023 and other federal proposals include provisions for medical monitoring programs for PFAS-exposed firefighters. Monitoring program participation does not waive your litigation rights.

Before your first attorney consultation, assembling a strong documentation package dramatically increases the speed and quality of the case assessment.

Employment History

• Name and address of every employer where you handled AFFF
• Dates of employment (start and end)
• Job title and specific AFFF-related duties
• Names of supervisors who can confirm your role

AFFF Use Records

• Training records showing AFFF exercises
• Incident reports where AFFF was deployed
• Purchasing records or inventory logs showing AFFF procurement at your facility
• FOIA request to your base or municipal employer for AFFF safety data sheets

Medical Records

• Pathology report confirming cancer diagnosis
• Surgical/biopsy reports
• Oncologist treatment notes
• Current prescription records (documenting ongoing treatment costs)
• Family physician notes mentioning occupational exposure history

Financial Records (for Economic Damages)

• Pay stubs or W-2s showing lost wages if you had to reduce or stop work
• Medical bills and insurance statements showing out-of-pocket costs
• Life insurance premium changes post-diagnosis

Having these materials organized before the consultation allows your attorney to provide a much more accurate case valuation.

---

This article is for informational purposes only and does not constitute legal advice. Consult a licensed attorney in your state to evaluate your specific claim. Statute of limitations deadlines are strict — if you have a cancer diagnosis and AFFF exposure history, contact an attorney before assuming you are time-barred.